RIfampicin COmbination Treatment versus Targeted oral Antimicrobial monotherapy for acute stafylococal prosthetic joint infection 

Compares whether clindamycin monotherapy in the oral treatment phase is non-inferior to traditional rifampicin/fluoroquinolones combination treatment for staphylococcal PJI treated with DAIR. Initiated by LUMC.

Click on the logo for practical information about the study.